Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans

Biochemical Pharmacology
D PessayreJ P Benhamou

Abstract

In rats, it has been shown that troleandomycin induces its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. To determine whether similar effects occur in humans, we studied hepatic microsomes from 6 untreated patients and 6 patients treated with troleandomycin, 2 g per os daily for 7 days. In the treated patients, NADPH-cytochrome c reductase activity was increased by 48%; total cytochrome P-450 concentration was also increased, but 33% of total cytochrome P-450 was complexed by a troleandomycin metabolite. The cytochrome P-450 Fe(II)-metabolite complex exhibited properties identical to those of the inactive complex formed in rats: it exhibited a Soret peak at 456 nm, was unable to bind CO, and was destroyed by addition of 50 microM potassium ferricyanide. We also measured the clearance of antipyrine in 6 other subjects. This clearance was decreased by 45% when measured again on te seventh day of the troleandomycin treatment. We conclude that repeated administration of troleandomycin induces microsomal enzymes, produces an inactive cytochrome P-450 Fe(II)-metabolite complex, and decreases the clearance of antipyrine in humans.

References

Mar 1, 1977·The Journal of Allergy and Clinical Immunology·M WeinbergerC Chidsey
Apr 15, 1976·Biochemical Pharmacology·D Pessayre, P Mazel
Mar 1, 1980·Annals of Internal Medicine·J P MiguetF Blanc
Mar 15, 1981·Biochemical Pharmacology·D PessayreJ P Benhamou

❮ Previous
Next ❯

Citations

Jan 1, 1986·European Journal of Clinical Pharmacology·D DebruyneM Moulin
Jan 1, 1987·European Journal of Drug Metabolism and Pharmacokinetics·W F EblingW J Jusko
Jan 20, 2005·European Journal of Clinical Pharmacology·Yan Chang, David E Moody
Jan 1, 1988·Pharmacology & Therapeutics·P H Beaune, F P Guengerich
Apr 1, 1988·Baillière's Clinical Gastroenterology·D Pessayre, D Larrey
Jan 1, 1997·Journal of Hepatology·D Larrey, G P Pageaux
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·P B WatkinsP S Guzelian
Sep 15, 1989·European Journal of Biochemistry·D MansuyJ P Battioni
Feb 1, 1993·Antimicrobial Agents and Chemotherapy·T D LindstromS A Wrighton
May 20, 1999·Research in Veterinary Science·A Anadón, L Reeve-johnson
Jul 1, 1997·Clinical and Experimental Pharmacology & Physiology·M Murray
Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Robert J RileyRichard Weaver
Nov 1, 1989·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M DelaforgeJ M Grognet
Jan 1, 1984·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A R Boobis, D S Davies
Mar 9, 2010·Drug Metabolism and Pharmacokinetics·Sasitorn AueviriyavitKan Chiba
Mar 14, 2012·Journal of Feline Medicine and Surgery·Masaaki KatayamaYuji Uzuka
May 3, 2019·Journal of Clinical Pharmacology·Evan D Kharasch, David J Greenblatt
Jun 24, 2017·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Chuong PhamKen Korzekwa
Mar 1, 1997·The Annals of Pharmacotherapy·V S WatkinsJ L Stotka
Aug 1, 1991·Journal of Chemotherapy·M CazzolaF Rossi
Jul 15, 1987·Biochemical Pharmacology·G AmouyalD Pessayre
Mar 15, 1983·Biochemical Pharmacology·D LarreyD Pessayre
May 1, 1991·Toxicology and Applied Pharmacology·H S RamsdellD L Eaton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.